Atherectomy Devices Market is expected to grow at a CAGR of 6.3% during the forecast period (2024-2031).  

Atherectomy is a minimally invasive endovascular procedure generally performed to remove atherosclerosis from blood vessels in the body. It is generally used to treat arteries. 

It can be used in veins and vascular bypass grafts as well. Atherectomy is also known as the Roto-rooter procedure as it cleans out the drainage pipes of the body. This procedure is performed in an outpatient setting, generally in the catheterization by a trained vascular surgeon or interventional radiologist. 

For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/atherectomy-devices-market 

 

 

Industry Segmentation 

By Product 

  • Directional Atherectomy Systems 

  • Orbital Atherectomy Systems 

  • Photo-Ablative (Laser) Atherectomy Systems 

  • Rotational Atherectomy Systems 

By Application 

  • Peripheral 

  • Cardiovascular 

  • Neurovascular 

By End User 

  • Hospitals 

  • Surgical Centers 

  • ASCs 

  • Research Laboratories 

  •  Academic Institutes 

 View Full Report: https://www.datamintelligence.com/research-report/atherectomy-devices-market 

Industry Key Players 

Major players are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson, and Company), Cardinal Health Inc., Koninklijke Philips NV, Medtronic, RA Medical Systems, Straub Medical, Terumo Corporation, Cardiovascular Systems Inc., Minnetronix Inc., Avinger Inc., Biomerics LLC and AngioDynamics Inc.